1.
Overall 7.4% of patients developed a hepatocellular carcinoma.
最后有7.4％的患者发生为肝细胞肝癌。
2.
The Expression of Endoglin, Matrix Metallo Proteinas 9, Vascular Endothelial Growth Factor in Hepatocellular Carcinoma;
CD105、MMP9和VEGF在肝细胞肝癌组织的表达
3.
Expression and Significance of E2f-3, Bcl-2 in Hepatocellular Carcinomar;
肝细胞肝癌中E2f-3、Bcl-2的表达及意义
4.
Comparative Study of CT and MR Imaging for the Diagnosis of Hepatocellular Carcinoma
肝细胞肝癌的CT及MR比较影像学分析
5.
Research Progress of Proteomics in Hepatocellular Carcinoma
肝细胞肝癌相关蛋白质组学研究进展
6.
Expression of Raf-1 in hepatocellular carcinoma
Raf-1在肝细胞肝癌组织的表达
7.
Expression of P-glycoprotein in Human Liver Cirrhosis and Hepatocellular Carcinoma
P-gp在人肝硬化及肝细胞肝癌中的表达及意义
8.
The Expression and Significance of S100A4、MMP-9 in Hepatic Carcinoma Cell Lines and Hepatocellular Carcinoma Tissue;
S100A4、MMP-9在肝癌细胞株、肝细胞肝癌组织中的表达及意义
9.
A new target in future treatment of liver cancer-liver cancer stem cells
未来肝癌治疗的新靶点-肝癌干细胞
10.
primary squamous cell carcinoma of liver
肝原发性鳞状细胞癌
11.
Intracellular Expression of Anti Hepatocellular Carcinoma (HCC) Single Chain Antibody (scFv) in HCC Cell Line;
细胞内表达抗肝癌单链抗体对肝癌细胞的作用
12.
Evaluation Study of Peripheral Cholangiocarcinoma and Hepatocellular Carcinoma Examined by MR;
胆管细胞癌与肝细胞癌的MR诊断价值
13.
Alphafetoprotein production is only seen in liver cell carcinoma.
甲胎蛋白的产生只见于肝细胞性肝癌。
14.
A liver cancer may have both hepatocellular as well as cholangiolar differentiation.
肝癌可具有肝细胞分化和胆管分化。
15.
Expression of matrix metalloproteinase-2 and matrix metaIloproteinase-9 in hepatocellular carcinoma;
MMP-2、MMP-9在肝细胞性肝癌的表达
16.
Study of syndecan-1 expression in hepatocellular carcinoma;
Syndecan-1在肝细胞性肝癌中表达的研究
17.
Relative Analysis between the Hepatic Oval Cell and Primary Hepatic Carcinoma
肝卵圆细胞与原发性肝癌相关性分析
18.
Hepatitis B virus X gene mutation and hepatocellular carcinoma
乙型肝炎病毒X基因突变与肝细胞癌